In the past ten years, the concept of injecting stem and progenitor cells to assist with
rebuilding damaged blood vessels and myocardial tissue after injury in the heart and …

Herein, we report the use of biodegradable nanoparticles (NPs) containing perfluoro-1, 5-
crown ether (PFCE), a fluorine-based compound (NP170-PFCE) with the capacity to track …

Recent pre-clinical and clinical studies indicate that certain exogenous stem cells and
biomaterials can preserve cardiac tissue after myocardial infarction. Regarding stem cells, a …

Abstract Cardiovascular Diseases (CVDs) are the primary cause of global mortality and
morbidity. Functional recovery of ischemic tissues and organs is dependent on establishing …

When ischemia, caused by diseases such as myocardial infarction (MI) or atherosclerotic
peripheral artery disease (PAD), happens in myocardium or skeletal muscles, the depletion …

Human pluripotent stem cells (hPSCs) are an unlimited source of endothelial and smooth
muscle cells for regenerative medicine, drug screening, and toxicology assays. Significant …